• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Saudi experts' recommendation for RSV prophylaxis in the era of COVID-19: Consensus from the Saudi Pediatric Pulmonology Association.沙特专家对新冠疫情时代呼吸道合胞病毒预防的建议：沙特儿科肺科学会的共识
Saudi Med J. 2021 Apr;42(4):355-362. doi: 10.15537/smj.2021.42.4.20200769.
2
Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study.沙特阿拉伯王国婴儿呼吸道合胞病毒（RSV）负担及全婴儿 RSV 保护的影响：一项建模研究。
Adv Ther. 2024 Apr;41(4):1419-1435. doi: 10.1007/s12325-024-02798-w. Epub 2024 Feb 15.
3
Effectiveness of Respiratory Syncytial Virus Immunoprophylaxis in Reducing Bronchiolitis Hospitalizations Among High-Risk Infants.呼吸道合胞病毒免疫预防在降低高危婴儿毛细支气管炎住院率中的效果。
Am J Epidemiol. 2018 Jul 1;187(7):1490-1500. doi: 10.1093/aje/kwy008.
4
Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-2017 epidemic season: a systematic review of seven Italian reports.2014 年美国儿科学会推荐意见的影响，以及意大利药品管理局因此对帕利珠单抗预防治疗的有限财政覆盖，对 2016-2017 年流行季早产儿中与 RSV 相关的住院治疗的影响：对七项意大利报告的系统评价。
Ital J Pediatr. 2019 Nov 9;45(1):139. doi: 10.1186/s13052-019-0736-5.
5
Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use.因呼吸道合胞病毒细支气管炎入住重症监护病房：帕利珠单抗使用前的全国性调查。
Pediatrics. 2003 Sep;112(3 Pt 1):548-52. doi: 10.1542/peds.112.3.548.
6
Respiratory syncytial virus bronchiolitis in congenital diaphragmatic hernia: A systematic review of prevalence rates and palivizumab prophylaxis.先天性膈疝患儿的呼吸道合胞病毒毛细支气管炎：患病率及帕利珠单抗预防率的系统评价。
Pediatr Pulmonol. 2022 Jan;57(1):239-244. doi: 10.1002/ppul.25717. Epub 2021 Oct 12.
7
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒（RSV）毛细支气管炎的免疫预防作用：亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
8
Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial.婴儿呼吸道合胞病毒预防和鼻咽微生物群直到 6 岁：MAKI 随机对照试验的亚分析。
Lancet Respir Med. 2020 Oct;8(10):1022-1031. doi: 10.1016/S2213-2600(19)30470-9. Epub 2020 Mar 20.
9
Respiratory Syncytial Virus Bronchiolitis in Children.儿童呼吸道合胞病毒细支气管炎
Am Fam Physician. 2017 Jan 15;95(2):94-99.
10
[Chemoprophylaxis with palivizumab in Andalusia (Spain). Results of the 2000-2001 respiratory syncytial virus epidemic].[西班牙安达卢西亚地区使用帕利珠单抗进行化学预防。2000 - 2001年呼吸道合胞病毒流行的结果]
An Esp Pediatr. 2002 Apr;56(4):293-7.

引用本文的文献

1
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce.长效单克隆抗体预防呼吸道合胞病毒疾病应用的系统评价与专家共识：ARMADA（推进呼吸道合胞病毒管理与疾病认知）工作组
Open Forum Infect Dis. 2025 Jul 2;12(7):ofaf396. doi: 10.1093/ofid/ofaf396. eCollection 2025 Jul.
2
Respiratory Syncytial Virus: A Narrative Review of Updates and Recent Advances in Epidemiology, Pathogenesis, Diagnosis, Management and Prevention.呼吸道合胞病毒：流行病学、发病机制、诊断、治疗与预防的最新进展及近期研究综述
J Clin Med. 2025 May 30;14(11):3880. doi: 10.3390/jcm14113880.
3
Palivizumab for the Prophylaxis of Respiratory Syncytial Virus Disease: Expert Opinion and Recommendations for the Gulf Cooperation Council Region.帕利珠单抗预防呼吸道合胞病毒疾病：海湾合作委员会地区专家意见与建议
Oman Med J. 2024 Sep 30;39(5):e667. doi: 10.5001/omj.2024.111. eCollection 2024 Sep.
4
Saudi Initiative of Bronchiolitis Diagnosis, Management, and Prevention 2024 updated consensus on the prevention of respiratory syncytial virus.《2024年沙特细支气管炎诊断、管理及预防倡议：呼吸道合胞病毒预防的最新共识》
Ann Thorac Med. 2024 Jul-Sep;19(3):190-200. doi: 10.4103/atm.atm_69_24. Epub 2024 Jul 4.
5
Epidemiologic and clinical updates on viral infections in Saudi Arabia.沙特阿拉伯病毒感染的流行病学与临床最新情况
Saudi Pharm J. 2024 Jul;32(7):102126. doi: 10.1016/j.jsps.2024.102126. Epub 2024 Jun 8.
6
Epidemiology and Risk Factor Analysis of Children with Bronchiolitis Admitted to the Intensive Care Unit at a Tertiary Care Center in Saudi Arabia.沙特阿拉伯一家三级护理中心收治的毛细支气管炎患儿的流行病学及危险因素分析
Children (Basel). 2023 Mar 30;10(4):646. doi: 10.3390/children10040646.
7
Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection.严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 大流行对儿童呼吸道合胞病毒感染流行病学的影响。
Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S130-S135. doi: 10.1093/cid/ciac373.
8
Screening for Neurodevelopmental Delay for Preterm Very Low Birth Weight Infants at Tertiary Care Center in Saudi Arabia.沙特阿拉伯三级医疗中心对极早早产低体重儿进行神经发育迟缓筛查。
Cureus. 2021 Dec 1;13(12):e20092. doi: 10.7759/cureus.20092. eCollection 2021 Dec.

本文引用的文献

1
Effects of the Coronavirus disease 2019 pandemic on routine pediatric immunization coverage rates at the main University Hospital in Saudi Arabia.2019年冠状病毒病大流行对沙特阿拉伯主要大学医院常规儿科免疫接种覆盖率的影响。
Saudi Med J. 2020 Nov;41(11):1197-1203. doi: 10.15537/smj.2020.11.25457.
2
Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: An Ecological Study.沙特阿拉伯王国2019冠状病毒病的流行病学：一项生态学研究。
Front Public Health. 2020 Sep 17;8:506. doi: 10.3389/fpubh.2020.00506. eCollection 2020.
3
Impact of lockdowns on the spread of COVID-19 in Saudi Arabia.封锁措施对沙特阿拉伯新冠病毒传播的影响。
Inform Med Unlocked. 2020;20:100420. doi: 10.1016/j.imu.2020.100420. Epub 2020 Sep 2.
4
Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19).年龄相关的轻度至中度 2019 冠状病毒病（COVID-19）患者鼻咽严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）水平的差异。
JAMA Pediatr. 2020 Sep 1;174(9):902-903. doi: 10.1001/jamapediatrics.2020.3651.
5
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.尼氏司他单抗单剂预防早产儿 RSV 感染。
N Engl J Med. 2020 Jul 30;383(5):415-425. doi: 10.1056/NEJMoa1913556.
6
Coronavirus Disease 2019-COVID-19.新型冠状病毒肺炎。
Clin Microbiol Rev. 2020 Jun 24;33(4). doi: 10.1128/CMR.00028-20. Print 2020 Sep 16.
7
Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study.沙特阿拉伯的 COVID-19 临床特征：一项全国性回顾性研究。
J Infect Public Health. 2020 Jul;13(7):920-925. doi: 10.1016/j.jiph.2020.05.026. Epub 2020 Jun 8.
8
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告：评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
9
The impact of novel coronavirus SARS-CoV-2 among healthcare workers in hospitals: An aerial overview.新型冠状病毒 SARS-CoV-2 对医院医护人员的影响：空中概览。
Am J Infect Control. 2020 Aug;48(8):915-917. doi: 10.1016/j.ajic.2020.05.020. Epub 2020 May 26.
10
Systematic Review of the Respiratory Syncytial Virus (RSV) Prevalence, Genotype Distribution, and Seasonality in Children from the Middle East and North Africa (MENA) Region.中东和北非（MENA）地区儿童呼吸道合胞病毒（RSV）流行率、基因型分布及季节性的系统评价
Microorganisms. 2020 May 11;8(5):713. doi: 10.3390/microorganisms8050713.

沙特专家对新冠疫情时代呼吸道合胞病毒预防的建议：沙特儿科肺科学会的共识

Saudi experts' recommendation for RSV prophylaxis in the era of COVID-19: Consensus from the Saudi Pediatric Pulmonology Association.

作者信息

Alharbi Adel S, Alzahrani Mohamed, Alodayani Abdulrahman N, Alhindi Mohamed Y, Alharbi Saleh, Alnemri Abdulrahman

机构信息

From the Department of Pediatrics (Alharbi A, Alodayani), Prince Sultan Military Medical City; from the Department of Pediatrics (Alzahrani), Security Forces Hospital; from the Pediatrics Department (Alnemri), College of Medicine, King Saud University, Riyadh; from the Department of Pediatrics (Alhindi), King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard; from the Department of Pediatrics (Alharbi S), Dr. Soliman Fakeeh Hospital, Jeddah; and from the Department of Pediatrics (Alharbi S), Umm Al-Qura University, Mecca, Kingdom of Saudi Arabia.

出版信息

Saudi Med J. 2021 Apr;42(4):355-362. doi: 10.15537/smj.2021.42.4.20200769.

DOI:10.15537/smj.2021.42.4.20200769
PMID:33795490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8128639/
Abstract

Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and viral pneumonia in pediatrics worldwide. In the Kingdom of Saudi Arabia (KSA), the prevalence of RSV is 23.5% in pediatric patients with acute lower respiratory tract illness. Coronavirus disease (COVID-19) poses critical public health and socioeconomic challenges in KSA. The Saudi Pediatric Pulmonology Association (SPPA), a subsidiary of the Saudi Thoracic Society (STS), developed a task force to determine the potential challenges and barriers to the RSV immunoprophylaxis program during the era of COVID-19 and to compose a practical, nationwide, and multidisciplinary approach to address these challenges. Some of the recommendations to manage these challenges include increasing the number of RSV immunoprophylaxis clinics, drive-thru visits, home-care services, and swift referrals to the RSV immunoprophylaxis program specialists. Additional training is required for healthcare personnel to add RSV immunoprophylaxis to the regular immunization schedule.

摘要

呼吸道合胞病毒（RSV）是全球范围内小儿毛细支气管炎和病毒性肺炎最常见的病因。在沙特阿拉伯王国（KSA），急性下呼吸道疾病小儿患者中RSV的患病率为23.5%。冠状病毒病（COVID-19）给沙特阿拉伯王国带来了严峻的公共卫生和社会经济挑战。沙特胸科学会（STS）的附属机构沙特小儿肺科学会（SPPA）成立了一个特别工作组，以确定COVID-19时代RSV免疫预防计划面临的潜在挑战和障碍，并制定一种切实可行、全国性的多学科方法来应对这些挑战。应对这些挑战的一些建议包括增加RSV免疫预防诊所的数量、免下车就诊、家庭护理服务，以及迅速转诊至RSV免疫预防计划专家处。医护人员需要接受额外培训，以便将RSV免疫预防纳入常规免疫接种计划。